Intratumoral heterogeneity in glioblastoma: don't forget the peritumoral brain zone.
about
Glioma Recurrence following Surgery: Peritumoral or Perilesional?Toward a noncytotoxic glioblastoma therapy: blocking MCP-1 with the MTZ RegimenGlioma Stem Cells and Their Microenvironments: Providers of Challenging Therapeutic TargetsHyperthermic Laser Ablation of Recurrent Glioblastoma Leads to Temporary Disruption of the Peritumoral Blood Brain BarrierA state-of-the-art review and guidelines for tumor treating fields treatment planning and patient follow-up in glioblastoma.Enhancement of radiosensitivity by the novel anticancer quinolone derivative vosaroxin in preclinical glioblastoma models.Radiomic features from the peritumoral brain parenchyma on treatment-naïve multi-parametric MR imaging predict long versus short-term survival in glioblastoma multiforme: Preliminary findings.Tumor microtubes convey resistance to surgical lesions and chemotherapy in gliomas.Conjugation Magnetic PAEEP-PLLA Nanoparticles with Lactoferrin as a Specific Targeting MRI Contrast Agent for Detection of Brain Glioma in Rats.Bacterial Carriers for Glioblastoma TherapyThe brain tissue response to surgical injury and its possible contribution to glioma recurrence.Frequent occurrence of therapeutically reversible CMV-associated encephalopathy during radiotherapy of the brain.EGFR Amplification and IDH Mutations in Glioblastoma Patients of the Northeast of Morocco.Simulating vasogenic brain edema using chronic VEGF infusionImpact of mesenchymal stem cells' secretome on glioblastoma pathophysiologyHuman mesenchymal stromal cells as cellular drug-delivery vectors for glioblastoma therapy: a good deal?Clinical Applications of Contrast-Enhanced Perfusion MRI Techniques in Gliomas: Recent Advances and Current Challenges.Locoregional Confinement and Major Clinical Benefit of 188Re-Loaded CXCR4-Targeted Nanocarriers in an Orthotopic Human to Mouse Model of Glioblastoma.CD4+ and Perivascular Foxp3+ T Cells in Glioma Correlate with Angiogenesis and Tumor Progression.PDGF Family Expression in Glioblastoma Multiforme: Data Compilation from Ivy Glioblastoma Atlas Project Database.5-Aminolevulinic Acid Guided Sampling of Glioblastoma Microenvironments Identifies Pro-Survival Signaling at Infiltrative Margins.Glioma resection and tumor recurrence: back to Semmelweis.TPD52L2 Impacts Proliferation, Invasiveness and Apoptosis of Glioblastoma Cells via Modulation of Wnt/β-catenin/Snail Signaling.Translational gap in ongoing clinical trials for glioma.The preliminary radiogenomics association between MR perfusion imaging parameters and genomic biomarkers, and their predictive performance of overall survival in patients with glioblastoma.In Vivo Detection of EGFRvIII in Glioblastoma via Perfusion Magnetic Resonance Imaging Signature Consistent with Deep Peritumoral Infiltration: The φ-Index.Histopathological Insights on Imaging Results of Intraoperative Magnetic Resonance Imaging, 5-Aminolevulinic Acid, and Intraoperative Ultrasound in Glioblastoma Surgery.Radiomic MRI signature reveals three distinct subtypes of glioblastoma with different clinical and molecular characteristics, offering prognostic value beyond IDH1.Cancer stem cells from peritumoral tissue of glioblastoma multiforme: the possible missing link between tumor development and progression.Intratumoral heterogeneity of oxygen metabolism and neovascularization uncovers 2 survival-relevant subgroups of IDH1 wild-type glioblastomaBrain metastases with poor vascular function are susceptible to pseudoprogression after stereotactic radiation surgery
P2860
Q26749630-4D622BDE-4FB5-4177-AB0E-EA97649FDF7FQ26749972-48764F86-798F-4DD3-A901-06D0419670DCQ26765758-73606A70-6286-42D7-ACEC-84F34F1F9959Q28550363-76EB25E4-69C9-43D2-91A6-7E69F39F1761Q31130812-7AAA4BE8-0E4B-474D-A9FE-402E8F3F3E98Q33728180-646758A6-895A-48D8-9267-195106BFEE58Q36173696-281A78BF-1B62-4A38-B180-C2ADBBCAECE0Q36349882-51D1506F-54C8-4C29-B58A-11486CEF8EB8Q36845110-B8A5C600-E93E-4261-B049-ADB1A79D148EQ37718566-07E8B719-F1C1-47D6-9301-CF0670AB271FQ38767957-D5F2B4E3-BF58-4555-8849-A474A4C4E259Q40707851-8AF311E9-D198-45FB-BF39-4144A9ECAC03Q41146626-59FF2A9A-F1F7-4C6B-829A-AF77D126F2FBQ41844840-6A6012D3-6CFC-432C-9667-0C35BB7FCB3CQ42284739-6FA220F2-2C54-4285-9A28-A717542A0DCBQ42368133-C4252F5A-417B-4F3B-A990-5026A4B15B71Q43376098-580B12CD-62E8-437B-BA2B-9479BF9C5090Q44243239-7097200A-9A86-4DF2-AF2D-D4318954334EQ47126472-373B567C-A311-49B5-B3FF-C24DDD39274AQ47131994-1AA48CD2-0ADF-4CAD-A1EF-48E6B4BF99E7Q47134867-6D0EECD7-0480-4F36-9ED8-80583030921EQ47148935-B19D4CD0-D905-479D-8907-D48C9198E102Q47437975-3E3D229F-14BC-4337-ABAE-F8BCB5E1F2B8Q48002716-9CDBFAAE-3F63-4B36-AA7D-44091B33BE1EQ48098509-FD99E65F-A20D-4EB1-B010-74568F57511AQ52097937-A8AD7651-8BFB-4405-BEFF-4D88E0496E7BQ53927976-F9A567A1-6727-4914-A6D3-3F8519EBDFF6Q55336403-426DBA9F-A07F-4C0B-9145-45A83C3B2F70Q55407495-A5DFCB41-338D-4D17-BF5C-FFCDB957B6D3Q57291654-06F0491C-70DA-4C46-A198-A34A7E78A157Q58131342-8F0A2517-4C58-4888-B04E-34B37BE48FD8
P2860
Intratumoral heterogeneity in glioblastoma: don't forget the peritumoral brain zone.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Intratumoral heterogeneity in glioblastoma: don't forget the peritumoral brain zone.
@ast
Intratumoral heterogeneity in glioblastoma: don't forget the peritumoral brain zone.
@en
type
label
Intratumoral heterogeneity in glioblastoma: don't forget the peritumoral brain zone.
@ast
Intratumoral heterogeneity in glioblastoma: don't forget the peritumoral brain zone.
@en
prefLabel
Intratumoral heterogeneity in glioblastoma: don't forget the peritumoral brain zone.
@ast
Intratumoral heterogeneity in glioblastoma: don't forget the peritumoral brain zone.
@en
P2860
P356
P1433
P1476
Intratumoral heterogeneity in glioblastoma: don't forget the peritumoral brain zone
@en
P2093
Anne Clavreul
Jean-Michel Lemée
P2860
P304
P356
10.1093/NEUONC/NOV119
P577
2015-07-22T00:00:00Z